SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma informs about loss of share certificates

10 Feb 2020 Evaluate

Aurobindo Pharma has informed that the Company has received the letters from the shareholders, named, Roop Chand Bansal, Ashok Sangappa, Vinod Kumar Bajaj, and Umesh Kumar Sushma, informing about the loss of share certificates and also requested for issue of duplicate share certificates. KFin Technologies, Registrar and Share Transfer Agents of the Company has recorded the stop transfer against the aforesaid shares and the Company has processing their requests for issue of duplicate share certificates.

The above information is a part of company's filings submitted to BSE.

Aurobindo Pharma Share Price

1408.20 17.05 (1.23%)
22-Apr-2026 13:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1664.00
Dr. Reddys Lab 1224.70
Cipla 1234.50
Zydus Lifesciences 929.35
Lupin 2311.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×